Selected research
Industry Growth & Trends
Global Tumor Targeting Peptides Industry Growth and Trends Forecast to 2032
Market perspective
The global Tumor Targeting Peptides market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Tumor Targeting Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Tumor Targeting Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Tumor Targeting Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Tumor Targeting Peptides include Advanced ChemTech, ASIA BIOSCIENCE CO, Bachem, Biorbyt, Cell Guidance Systems, CPC Scientific Inc, Danaher(Abcam), Merck KGaA and PEPTIDE INSTITUTE, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Tumor Targeting Peptides market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Tumor Targeting Peptides market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tumor Targeting Peptides market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tumor Targeting Peptides.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Tumor Targeting Peptides market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Tumor Targeting Peptides Market by Company
Advanced ChemTech
ASIA BIOSCIENCE CO
Bachem
Biorbyt
Cell Guidance Systems
CPC Scientific Inc
Danaher(Abcam)
Merck KGaA
PEPTIDE INSTITUTE
RayBiotech
Selleck Chemicals
TargetMol Chemicals
Cayman Chemical
QYAOBIO
Tumor Targeting Peptides Segment by Type
Therapeutic Targeting Peptides
Imaging Targeting Peptides
Tumor Targeting Peptides Segment by Application
Scientific Research
Pharmaceuticals
Tumor Targeting Peptides Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Targeting Peptides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tumor Targeting Peptides and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Targeting Peptides.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor Targeting Peptides manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Tumor Targeting Peptides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
List of Tables
Table 1. Major Company of Therapeutic Targeting Peptides
Table 2. Major Company of Imaging Targeting Peptides
Table 3. Global Tumor Targeting Peptides Sales by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Global Tumor Targeting Peptides Sales by Type (2021-2026) & (Kg)
Table 5. Global Tumor Targeting Peptides Sales Market Share in Volume by Type (2021-2026)
Table 6. Global Tumor Targeting Peptides Sales by Type (2021-2026) & (US$ Million)
Table 7. Global Tumor Targeting Peptides Sales Market Share in Value by Type (2021-2026)
Table 8. Global Tumor Targeting Peptides Price by Type (2021-2026) & (US$/g)
Table 9. Global Tumor Targeting Peptides Sales by Type (2027-2032) & (Kg)
Table 10. Global Tumor Targeting Peptides Sales Market Share in Volume by Type (2027-2032)
Table 11. Global Tumor Targeting Peptides Sales by Type (2027-2032) & (US$ Million)
Table 12. Global Tumor Targeting Peptides Sales Market Share in Value by Type (2027-2032)
Table 13. Global Tumor Targeting Peptides Price by Type (2027-2032) & (US$/g)
Table 14. North America Tumor Targeting Peptides Sales by Type (2021-2026) & (Kg)
Table 15. North America Tumor Targeting Peptides Sales by Type (2021-2026) & (US$ Million)
Table 16. Europe Tumor Targeting Peptides Sales by Type (2021-2026) & (Kg)
Table 17. Europe Tumor Targeting Peptides Sales by Type (2021-2026) & (US$ Million)
Table 18. Asia-Pacific Tumor Targeting Peptides Sales by Type (2021-2026) & (Kg)
Table 19. Asia-Pacific Tumor Targeting Peptides Sales by Type (2021-2026) & (US$ Million)
Table 20. Latin America Tumor Targeting Peptides Sales by Type (2021-2026) & (Kg)
Table 21. Latin America Tumor Targeting Peptides Sales by Type (2021-2026) & (US$ Million)
Table 22. Middle East and Africa Tumor Targeting Peptides Sales by Type (2021-2026) & (Kg)
Table 23. Middle East and Africa Tumor Targeting Peptides Sales by Type (2021-2026) & (US$ Million)
Table 24. Tumor Targeting Peptides Industry Trends
Table 25. Tumor Targeting Peptides Industry Drivers
Table 26. Tumor Targeting Peptides Industry Opportunities and Challenges
Table 27. Tumor Targeting Peptides Industry Restraints
Table 28. Global Tumor Targeting Peptides Sales Revenue by Company (US$ Million) & (2021-2026)
Table 29. Global Tumor Targeting Peptides Revenue Market Share by Company (2021-2026)
Table 30. Global Tumor Targeting Peptides Sales by Company (2021-2026) & (Kg)
Table 31. Global Tumor Targeting Peptides Sales Share by Company (2021-2026)
Table 32. Global Tumor Targeting Peptides Market Price by Company (2021-2026) & (US$/g)
Table 33. Global Tumor Targeting Peptides Industry Company Ranking, 2024 VS 2025 VS 2026
Table 34. Global Tumor Targeting Peptides Major Company Production Sites and Headquarters
Table 35. Global Tumor Targeting Peptides Company, Product Type & Application
Table 36. Global Tumor Targeting Peptides Company Establishment Date
Table 37. Global Company Market Concentration Ratio (CR5 and HHI)
Table 38. Global Tumor Targeting Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 39. Global Tumor Targeting Peptides Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032
Table 40. Global Tumor Targeting Peptides Sales by Region (2021-2026) & (Kg)
Table 41. Global Tumor Targeting Peptides Sales Market Share in Volume by Region (2021-2026)
Table 42. Global Tumor Targeting Peptides Sales by Region (2021-2026) & (US$ Million)
Table 43. Global Tumor Targeting Peptides Sales Market Share in Value by Region (2021-2026)
Table 44. Global Tumor Targeting Peptides Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 45. Global Tumor Targeting Peptides Sales by Region (2027-2032) & (Kg)
Table 46. Global Tumor Targeting Peptides Sales Market Share in Volume by Region (2027-2032)
Table 47. Global Tumor Targeting Peptides Sales by Region (2027-2032) & (US$ Million)
Table 48. Global Tumor Targeting Peptides Sales Market Share in Value by Region (2027-2032)
Table 49. Global Tumor Targeting Peptides Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2027-2032)
Table 50. Global Tumor Targeting Peptides Sales by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 51. Global Tumor Targeting Peptides Sales by Application (2021-2026) & (Kg)
Table 52. Global Tumor Targeting Peptides Sales Market Share in Volume by Application (2021-2026)
Table 53. Global Tumor Targeting Peptides Sales by Application (2021-2026) & (US$ Million)
Table 54. Global Tumor Targeting Peptides Sales Market Share in Value by Application (2021-2026)
Table 55. Global Tumor Targeting Peptides Price by Application (2021-2026) & (US$/g)
Table 56. Global Tumor Targeting Peptides Sales by Application (2027-2032) & (Kg)
Table 57. Global Tumor Targeting Peptides Sales Market Share in Volume by Application (2027-2032)
Table 58. Global Tumor Targeting Peptides Sales by Application (2027-2032) & (US$ Million)
Table 59. Global Tumor Targeting Peptides Sales Market Share in Value by Application (2027-2032)
Table 60. Global Tumor Targeting Peptides Price by Application (2027-2032) & (US$/g)
Table 61. North America Tumor Targeting Peptides Sales by Application (2021-2026) & (Kg)
Table 62. North America Tumor Targeting Peptides Sales by Application (2021-2026) & (US$ Million)
Table 63. Europe Tumor Targeting Peptides Sales by Application (2021-2026) & (Kg)
Table 64. Europe Tumor Targeting Peptides Sales by Application (2021-2026) & (US$ Million)
Table 65. Asia-Pacific Tumor Targeting Peptides Sales by Application (2021-2026) & (Kg)
Table 66. Asia-Pacific Tumor Targeting Peptides Sales by Application (2021-2026) & (US$ Million)
Table 67. Latin America Tumor Targeting Peptides Sales by Application (2021-2026) & (Kg)
Table 68. Latin America Tumor Targeting Peptides Sales by Application (2021-2026) & (US$ Million)
Table 69. Middle East and Africa Tumor Targeting Peptides Sales by Application (2021-2026) & (Kg)
Table 70. Middle East and Africa Tumor Targeting Peptides Sales by Application (2021-2026) & (US$ Million)
Table 71. Advanced ChemTech Company Information
Table 72. Advanced ChemTech Business Overview
Table 73. Advanced ChemTech Tumor Targeting Peptides Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 74. Advanced ChemTech Tumor Targeting Peptides Product Portfolio
Table 75. Advanced ChemTech Recent Development
Table 76. ASIA BIOSCIENCE CO Company Information
Table 77. ASIA BIOSCIENCE CO Business Overview
Table 78. ASIA BIOSCIENCE CO Tumor Targeting Peptides Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 79. ASIA BIOSCIENCE CO Tumor Targeting Peptides Product Portfolio
Table 80. ASIA BIOSCIENCE CO Recent Development
Table 81. Bachem Company Information
Table 82. Bachem Business Overview
Table 83. Bachem Tumor Targeting Peptides Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 84. Bachem Tumor Targeting Peptides Product Portfolio
Table 85. Bachem Recent Development
Table 86. Biorbyt Company Information
Table 87. Biorbyt Business Overview
Table 88. Biorbyt Tumor Targeting Peptides Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 89. Biorbyt Tumor Targeting Peptides Product Portfolio
Table 90. Biorbyt Recent Development
Table 91. Cell Guidance Systems Company Information
Table 92. Cell Guidance Systems Business Overview
Table 93. Cell Guidance Systems Tumor Targeting Peptides Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 94. Cell Guidance Systems Tumor Targeting Peptides Product Portfolio
Table 95. Cell Guidance Systems Recent Development
Table 96. CPC Scientific Inc Company Information
Table 97. CPC Scientific Inc Business Overview
Table 98. CPC Scientific Inc Tumor Targeting Peptides Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 99. CPC Scientific Inc Tumor Targeting Peptides Product Portfolio
Table 100. CPC Scientific Inc Recent Development
Table 101. Danaher(Abcam) Company Information
Table 102. Danaher(Abcam) Business Overview
Table 103. Danaher(Abcam) Tumor Targeting Peptides Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 104. Danaher(Abcam) Tumor Targeting Peptides Product Portfolio
Table 105. Danaher(Abcam) Recent Development
Table 106. Merck KGaA Company Information
Table 107. Merck KGaA Business Overview
Table 108. Merck KGaA Tumor Targeting Peptides Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 109. Merck KGaA Tumor Targeting Peptides Product Portfolio
Table 110. Merck KGaA Recent Development
Table 111. PEPTIDE INSTITUTE Company Information
Table 112. PEPTIDE INSTITUTE Business Overview
Table 113. PEPTIDE INSTITUTE Tumor Targeting Peptides Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 114. PEPTIDE INSTITUTE Tumor Targeting Peptides Product Portfolio
Table 115. PEPTIDE INSTITUTE Recent Development
Table 116. RayBiotech Company Information
Table 117. RayBiotech Business Overview
Table 118. RayBiotech Tumor Targeting Peptides Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 119. RayBiotech Tumor Targeting Peptides Product Portfolio
Table 120. RayBiotech Recent Development
Table 121. Selleck Chemicals Company Information
Table 122. Selleck Chemicals Business Overview
Table 123. Selleck Chemicals Tumor Targeting Peptides Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 124. Selleck Chemicals Tumor Targeting Peptides Product Portfolio
Table 125. Selleck Chemicals Recent Development
Table 126. TargetMol Chemicals Company Information
Table 127. TargetMol Chemicals Business Overview
Table 128. TargetMol Chemicals Tumor Targeting Peptides Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 129. TargetMol Chemicals Tumor Targeting Peptides Product Portfolio
Table 130. TargetMol Chemicals Recent Development
Table 131. Cayman Chemical Company Information
Table 132. Cayman Chemical Business Overview
Table 133. Cayman Chemical Tumor Targeting Peptides Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 134. Cayman Chemical Tumor Targeting Peptides Product Portfolio
Table 135. Cayman Chemical Recent Development
Table 136. QYAOBIO Company Information
Table 137. QYAOBIO Business Overview
Table 138. QYAOBIO Tumor Targeting Peptides Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 139. QYAOBIO Tumor Targeting Peptides Product Portfolio
Table 140. QYAOBIO Recent Development
Table 141. North America Tumor Targeting Peptides Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032
Table 142. North America Tumor Targeting Peptides Sales by Country (2021-2026) & (Kg)
Table 143. North America Tumor Targeting Peptides Sales Market Share by Country (2021-2026)
Table 144. North America Tumor Targeting Peptides Sales Forecast by Country (2027-2032) & (Kg)
Table 145. North America Tumor Targeting Peptides Sales Market Share Forecast by Country (2027-2032)
Table 146. North America Tumor Targeting Peptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 147. North America Tumor Targeting Peptides Market Size by Country (2021-2026) & (US$ Million)
Table 148. North America Tumor Targeting Peptides Market Share by Country (2021-2026)
Table 149. North America Tumor Targeting Peptides Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 150. North America Tumor Targeting Peptides Market Share Forecast by Country (2027-2032)
Table 151. Europe Tumor Targeting Peptides Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032
Table 152. Europe Tumor Targeting Peptides Sales by Country (2021-2026) & (Kg)
Table 153. Europe Tumor Targeting Peptides Sales Market Share by Country (2021-2026)
Table 154. Europe Tumor Targeting Peptides Sales Forecast by Country (2027-2032) & (Kg)
Table 155. Europe Tumor Targeting Peptides Sales Market Share Forecast by Country (2027-2032)
Table 156. Europe Tumor Targeting Peptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 157. Europe Tumor Targeting Peptides Market Size by Country (2021-2026) & (US$ Million)
Table 158. Europe Tumor Targeting Peptides Market Share by Country (2021-2026)
Table 159. Europe Tumor Targeting Peptides Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 160. Europe Tumor Targeting Peptides Market Share Forecast by Country (2027-2032)
Table 161. Asia-Pacific Tumor Targeting Peptides Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032
Table 162. Asia-Pacific Tumor Targeting Peptides Sales by Country (2021-2026) & (Kg)
Table 163. Asia-Pacific Tumor Targeting Peptides Sales Market Share by Country (2021-2026)
Table 164. Asia-Pacific Tumor Targeting Peptides Sales Forecast by Country (2027-2032) & (Kg)
Table 165. Asia-Pacific Tumor Targeting Peptides Sales Market Share Forecast by Country (2027-2032)
Table 166. Asia-Pacific Tumor Targeting Peptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 167. Asia-Pacific Tumor Targeting Peptides Market Size by Country (2021-2026) & (US$ Million)
Table 168. Asia-Pacific Tumor Targeting Peptides Market Share by Country (2021-2026)
Table 169. Asia-Pacific Tumor Targeting Peptides Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 170. Asia-Pacific Tumor Targeting Peptides Market Share Forecast by Country (2027-2032)
Table 171. Latin America Tumor Targeting Peptides Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032
Table 172. Latin America Tumor Targeting Peptides Sales by Country (2021-2026) & (Kg)
Table 173. Latin America Tumor Targeting Peptides Sales Market Share by Country (2021-2026)
Table 174. Latin America Tumor Targeting Peptides Sales Forecast by Country (2027-2032) & (Kg)
Table 175. Latin America Tumor Targeting Peptides Sales Market Share Forecast by Country (2027-2032)
Table 176. Latin America Tumor Targeting Peptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 177. Latin America Tumor Targeting Peptides Market Size by Country (2021-2026) & (US$ Million)
Table 178. Latin America Tumor Targeting Peptides Market Share by Country (2021-2026)
Table 179. Latin America Tumor Targeting Peptides Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 180. Latin America Tumor Targeting Peptides Market Share Forecast by Country (2027-2032)
Table 181. Middle East and Africa Tumor Targeting Peptides Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032
Table 182. Middle East and Africa Tumor Targeting Peptides Sales by Country (2021-2026) & (Kg)
Table 183. Middle East and Africa Tumor Targeting Peptides Sales Market Share by Country (2021-2026)
Table 184. Middle East and Africa Tumor Targeting Peptides Sales Forecast by Country (2027-2032) & (Kg)
Table 185. Middle East and Africa Tumor Targeting Peptides Sales Market Share Forecast by Country (2027-2032)
Table 186. Middle East and Africa Tumor Targeting Peptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 187. Middle East and Africa Tumor Targeting Peptides Market Size by Country (2021-2026) & (US$ Million)
Table 188. Middle East and Africa Tumor Targeting Peptides Market Share by Country (2021-2026)
Table 189. Middle East and Africa Tumor Targeting Peptides Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 190. Middle East and Africa Tumor Targeting Peptides Market Share Forecast by Country (2027-2032)
Table 191. Key Raw Materials
Table 192. Raw Materials Key Suppliers
Table 193. Tumor Targeting Peptides Distributors List
Table 194. Tumor Targeting Peptides Customers List
Table 195. Research Programs/Design for This Report
Table 196. Authors List of This Report
Table 197. Secondary Sources
Table 198. Primary Sources
List of Figures
Figure 1. Tumor Targeting Peptides Image
Figure 2. Global Tumor Targeting Peptides Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Tumor Targeting Peptides Market Size (2021-2032) & (US$ Million)
Figure 4. Global Tumor Targeting Peptides Sales (2021-2032) & (Kg)
Figure 5. Therapeutic Targeting Peptides Image
Figure 6. Global Therapeutic Targeting Peptides Sales YoY Growth (2021-2032) & (Kg)
Figure 7. Imaging Targeting Peptides Image
Figure 8. Global Imaging Targeting Peptides Sales YoY Growth (2021-2032) & (Kg)
Figure 9. Global Tumor Targeting Peptides Market Size Overview by Type (2021-2032) & (US$ Million)
Figure 10. Global Tumor Targeting Peptides Market Share by Type 2025 VS 2032
Figure 11. North America Tumor Targeting Peptides Sales Market Share in Volume by Type in 2025
Figure 12. North America Tumor Targeting Peptides Sales Market Share in Value by Type in 2025
Figure 13. Europe Tumor Targeting Peptides Sales Market Share in Volume by Type in 2025
Figure 14. Europe Tumor Targeting Peptides Sales Market Share in Value by Type in 2025
Figure 15. Asia-Pacific Tumor Targeting Peptides Sales Market Share in Volume by Type in 2025
Figure 16. Asia-Pacific Tumor Targeting Peptides Sales Market Share in Value by Type in 2025
Figure 17. Latin America Tumor Targeting Peptides Sales Market Share in Volume by Type in 2025
Figure 18. Latin America Tumor Targeting Peptides Sales Market Share in Value by Type in 2025
Figure 19. Middle East and Africa Tumor Targeting Peptides Sales Market Share in Volume by Type in 2025
Figure 20. Middle East and Africa Tumor Targeting Peptides Sales Market Share in Value by Type in 2025
Figure 21. Global Top 5 and 10 Tumor Targeting Peptides Players Market Share by Revenue in 2025
Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 23. Scientific Research Image
Figure 24. Global Scientific Research Sales YoY Growth (2021-2032) & (Kg)
Figure 25. Pharmaceuticals Image
Figure 26. Global Pharmaceuticals Sales YoY Growth (2021-2032) & (Kg)
Figure 27. Global Tumor Targeting Peptides Market Size Overview by Application (2021-2032) & (US$ Million)
Figure 28. Global Tumor Targeting Peptides Market Share by Application 2025 VS 2032
Figure 29. North America Tumor Targeting Peptides Sales Market Share in Volume by Application in 2025
Figure 30. North America Tumor Targeting Peptides Sales Market Share in Value by Application in 2025
Figure 31. Europe Tumor Targeting Peptides Sales Market Share in Volume by Application in 2025
Figure 32. Europe Tumor Targeting Peptides Sales Market Share in Value by Application in 2025
Figure 33. Asia-Pacific Tumor Targeting Peptides Sales Market Share in Volume by Application in 2025
Figure 34. Asia-Pacific Tumor Targeting Peptides Sales Market Share in Value by Application in 2025
Figure 35. Latin America Tumor Targeting Peptides Sales Market Share in Volume by Application in 2025
Figure 36. Latin America Tumor Targeting Peptides Sales Market Share in Value by Application in 2025
Figure 37. Middle East and Africa Tumor Targeting Peptides Sales Market Share in Volume by Application in 2025
Figure 38. Middle East and Africa Tumor Targeting Peptides Sales Market Share in Value by Application in 2025
Figure 39. North America Tumor Targeting Peptides Sales by Country: 2021 VS 2025 VS 2032 (Kg)
Figure 40. North America Tumor Targeting Peptides Sales Share by Country: 2021 VS 2025 VS 2032
Figure 41. North America Tumor Targeting Peptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 42. North America Tumor Targeting Peptides Market Share by Country: 2021 VS 2025 VS 2032
Figure 43. Europe Tumor Targeting Peptides Sales by Country: 2021 VS 2025 VS 2032 (Kg)
Figure 44. Europe Tumor Targeting Peptides Sales Share by Country: 2021 VS 2025 VS 2032
Figure 45. Europe Tumor Targeting Peptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 46. Europe Tumor Targeting Peptides Market Share by Country: 2021 VS 2025 VS 2032
Figure 47. Asia-Pacific Tumor Targeting Peptides Sales by Country: 2021 VS 2025 VS 2032 (Kg)
Figure 48. Asia-Pacific Tumor Targeting Peptides Sales Share by Country: 2021 VS 2025 VS 2032
Figure 49. Asia-Pacific Tumor Targeting Peptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 50. Asia-Pacific Tumor Targeting Peptides Market Share by Country: 2021 VS 2025 VS 2032
Figure 51. Latin America Tumor Targeting Peptides Sales by Country: 2021 VS 2025 VS 2032 (Kg)
Figure 52. Latin America Tumor Targeting Peptides Sales Share by Country: 2021 VS 2025 VS 2032
Figure 53. Latin America Tumor Targeting Peptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 54. Latin America Tumor Targeting Peptides Market Share by Country: 2021 VS 2025 VS 2032
Figure 55. Middle East and Africa Tumor Targeting Peptides Sales by Country: 2021 VS 2025 VS 2032 (Kg)
Figure 56. Middle East and Africa Tumor Targeting Peptides Sales Share by Country: 2021 VS 2025 VS 2032
Figure 57. Middle East and Africa Tumor Targeting Peptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 58. Middle East and Africa Tumor Targeting Peptides Market Share by Country: 2021 VS 2025 VS 2032
Figure 59. Tumor Targeting Peptides Value Chain
Figure 60. Key Raw Materials Price
Figure 61. Manufacturing Cost Structure
Figure 62. Tumor Targeting Peptides Production Mode & Process
Figure 63. Direct Comparison with Distribution Share
Figure 64. Distributors Profiles
Figure 65. Years Considered
Figure 66. Research Process
Figure 67. Key Executives Interviewed
Scope & coverage.
Types
- Therapeutic Targeting Peptides
- Imaging Targeting Peptides
Applications
- Scientific Research
- Pharmaceuticals
Companies covered
- Advanced ChemTech
- ASIA BIOSCIENCE CO
- Bachem
- Biorbyt
- Cell Guidance Systems
- CPC Scientific Inc
- Danaher(Abcam)
- Merck KGaA
- PEPTIDE INSTITUTE
- RayBiotech
- Selleck Chemicals
- TargetMol Chemicals
- Cayman Chemical
- QYAOBIO
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Tumor Targeting Peptides Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Tumor Targeting Peptides Sales Estimates and Forecasts (2021-2032)
- 1.3 Tumor Targeting Peptides Market by Type
- 1.3.1 Therapeutic Targeting Peptides
- 1.3.2 Imaging Targeting Peptides
- 1.4 Global Tumor Targeting Peptides Market Size by Type
- 1.4.1 Global Tumor Targeting Peptides Market Size Overview by Type (2021-2032)
- 1.4.2 Global Tumor Targeting Peptides Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Tumor Targeting Peptides Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Tumor Targeting Peptides Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Tumor Targeting Peptides Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Tumor Targeting Peptides Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Tumor Targeting Peptides Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Tumor Targeting Peptides Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Tumor Targeting Peptides Industry Trends
- 2.2 Tumor Targeting Peptides Industry Drivers
- 2.3 Tumor Targeting Peptides Industry Opportunities and Challenges
- 2.4 Tumor Targeting Peptides Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Tumor Targeting Peptides Revenue (2021-2026)
- 3.2 Global Top Players by Tumor Targeting Peptides Sales (2021-2026)
- 3.3 Global Top Players by Tumor Targeting Peptides Price (2021-2026)
- 3.4 Global Tumor Targeting Peptides Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Tumor Targeting Peptides Major Company Production Sites & Headquarters
- 3.6 Global Tumor Targeting Peptides Company, Product Type & Application
- 3.7 Global Tumor Targeting Peptides Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Tumor Targeting Peptides Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Tumor Targeting Peptides Players Market Share by Revenue in 2025
- 3.8.3 2025 Tumor Targeting Peptides Tier 1, Tier 2, and Tier 3
4 Tumor Targeting Peptides Regional Status and Outlook
- 4.1 Global Tumor Targeting Peptides Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Tumor Targeting Peptides Historic Market Size by Region
- 4.2.1 Global Tumor Targeting Peptides Sales in Volume by Region (2021-2026)
- 4.2.2 Global Tumor Targeting Peptides Sales in Value by Region (2021-2026)
- 4.2.3 Global Tumor Targeting Peptides Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Tumor Targeting Peptides Forecasted Market Size by Region
- 4.3.1 Global Tumor Targeting Peptides Sales in Volume by Region (2027-2032)
- 4.3.2 Global Tumor Targeting Peptides Sales in Value by Region (2027-2032)
- 4.3.3 Global Tumor Targeting Peptides Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Tumor Targeting Peptides by Application
- 5.1 Tumor Targeting Peptides Market by Application
- 5.1.1 Scientific Research
- 5.1.2 Pharmaceuticals
- 5.2 Global Tumor Targeting Peptides Market Size by Application
- 5.2.1 Global Tumor Targeting Peptides Market Size Overview by Application (2021-2032)
- 5.2.2 Global Tumor Targeting Peptides Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Tumor Targeting Peptides Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Tumor Targeting Peptides Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Tumor Targeting Peptides Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Tumor Targeting Peptides Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Tumor Targeting Peptides Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Tumor Targeting Peptides Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Advanced ChemTech
- 6.1.1 Advanced ChemTech Company Information
- 6.1.2 Advanced ChemTech Business Overview
- 6.1.3 Advanced ChemTech Tumor Targeting Peptides Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Advanced ChemTech Tumor Targeting Peptides Product Portfolio
- 6.1.5 Advanced ChemTech Recent Developments
- 6.2 ASIA BIOSCIENCE CO
- 6.2.1 ASIA BIOSCIENCE CO Company Information
- 6.2.2 ASIA BIOSCIENCE CO Business Overview
- 6.2.3 ASIA BIOSCIENCE CO Tumor Targeting Peptides Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 ASIA BIOSCIENCE CO Tumor Targeting Peptides Product Portfolio
- 6.2.5 ASIA BIOSCIENCE CO Recent Developments
- 6.3 Bachem
- 6.3.1 Bachem Company Information
- 6.3.2 Bachem Business Overview
- 6.3.3 Bachem Tumor Targeting Peptides Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Bachem Tumor Targeting Peptides Product Portfolio
- 6.3.5 Bachem Recent Developments
- 6.4 Biorbyt
- 6.4.1 Biorbyt Company Information
- 6.4.2 Biorbyt Business Overview
- 6.4.3 Biorbyt Tumor Targeting Peptides Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Biorbyt Tumor Targeting Peptides Product Portfolio
- 6.4.5 Biorbyt Recent Developments
- 6.5 Cell Guidance Systems
- 6.5.1 Cell Guidance Systems Company Information
- 6.5.2 Cell Guidance Systems Business Overview
- 6.5.3 Cell Guidance Systems Tumor Targeting Peptides Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Cell Guidance Systems Tumor Targeting Peptides Product Portfolio
- 6.5.5 Cell Guidance Systems Recent Developments
- 6.6 CPC Scientific Inc
- 6.6.1 CPC Scientific Inc Company Information
- 6.6.2 CPC Scientific Inc Business Overview
- 6.6.3 CPC Scientific Inc Tumor Targeting Peptides Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 CPC Scientific Inc Tumor Targeting Peptides Product Portfolio
- 6.6.5 CPC Scientific Inc Recent Developments
- 6.7 Danaher(Abcam)
- 6.7.1 Danaher(Abcam) Company Information
- 6.7.2 Danaher(Abcam) Business Overview
- 6.7.3 Danaher(Abcam) Tumor Targeting Peptides Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Danaher(Abcam) Tumor Targeting Peptides Product Portfolio
- 6.7.5 Danaher(Abcam) Recent Developments
- 6.8 Merck KGaA
- 6.8.1 Merck KGaA Company Information
- 6.8.2 Merck KGaA Business Overview
- 6.8.3 Merck KGaA Tumor Targeting Peptides Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Merck KGaA Tumor Targeting Peptides Product Portfolio
- 6.8.5 Merck KGaA Recent Developments
- 6.9 PEPTIDE INSTITUTE
- 6.9.1 PEPTIDE INSTITUTE Company Information
- 6.9.2 PEPTIDE INSTITUTE Business Overview
- 6.9.3 PEPTIDE INSTITUTE Tumor Targeting Peptides Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 PEPTIDE INSTITUTE Tumor Targeting Peptides Product Portfolio
- 6.9.5 PEPTIDE INSTITUTE Recent Developments
- 6.10 RayBiotech
- 6.10.1 RayBiotech Company Information
- 6.10.2 RayBiotech Business Overview
- 6.10.3 RayBiotech Tumor Targeting Peptides Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 RayBiotech Tumor Targeting Peptides Product Portfolio
- 6.10.5 RayBiotech Recent Developments
- 6.11 Selleck Chemicals
- 6.11.1 Selleck Chemicals Company Information
- 6.11.2 Selleck Chemicals Business Overview
- 6.11.3 Selleck Chemicals Tumor Targeting Peptides Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Selleck Chemicals Tumor Targeting Peptides Product Portfolio
- 6.11.5 Selleck Chemicals Recent Developments
- 6.12 TargetMol Chemicals
- 6.12.1 TargetMol Chemicals Company Information
- 6.12.2 TargetMol Chemicals Business Overview
- 6.12.3 TargetMol Chemicals Tumor Targeting Peptides Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 TargetMol Chemicals Tumor Targeting Peptides Product Portfolio
- 6.12.5 TargetMol Chemicals Recent Developments
- 6.13 Cayman Chemical
- 6.13.1 Cayman Chemical Company Information
- 6.13.2 Cayman Chemical Business Overview
- 6.13.3 Cayman Chemical Tumor Targeting Peptides Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Cayman Chemical Tumor Targeting Peptides Product Portfolio
- 6.13.5 Cayman Chemical Recent Developments
- 6.14 QYAOBIO
- 6.14.1 QYAOBIO Company Information
- 6.14.2 QYAOBIO Business Overview
- 6.14.3 QYAOBIO Tumor Targeting Peptides Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 QYAOBIO Tumor Targeting Peptides Product Portfolio
- 6.14.5 QYAOBIO Recent Developments
7 North America by Country
- 7.1 North America Tumor Targeting Peptides Sales by Country
- 7.1.1 North America Tumor Targeting Peptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Tumor Targeting Peptides Sales by Country (2021-2026)
- 7.1.3 North America Tumor Targeting Peptides Sales Forecast by Country (2027-2032)
- 7.2 North America Tumor Targeting Peptides Market Size by Country
- 7.2.1 North America Tumor Targeting Peptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Tumor Targeting Peptides Market Size by Country (2021-2026)
- 7.2.3 North America Tumor Targeting Peptides Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Tumor Targeting Peptides Sales by Country
- 8.1.1 Europe Tumor Targeting Peptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Tumor Targeting Peptides Sales by Country (2021-2026)
- 8.1.3 Europe Tumor Targeting Peptides Sales Forecast by Country (2027-2032)
- 8.2 Europe Tumor Targeting Peptides Market Size by Country
- 8.2.1 Europe Tumor Targeting Peptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Tumor Targeting Peptides Market Size by Country (2021-2026)
- 8.2.3 Europe Tumor Targeting Peptides Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Tumor Targeting Peptides Sales by Country
- 9.1.1 Asia-Pacific Tumor Targeting Peptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Tumor Targeting Peptides Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Tumor Targeting Peptides Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Tumor Targeting Peptides Market Size by Country
- 9.2.1 Asia-Pacific Tumor Targeting Peptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Tumor Targeting Peptides Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Tumor Targeting Peptides Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Tumor Targeting Peptides Sales by Country
- 10.1.1 South America Tumor Targeting Peptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Tumor Targeting Peptides Sales by Country (2021-2026)
- 10.1.3 South America Tumor Targeting Peptides Sales Forecast by Country (2027-2032)
- 10.2 South America Tumor Targeting Peptides Market Size by Country
- 10.2.1 South America Tumor Targeting Peptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Tumor Targeting Peptides Market Size by Country (2021-2026)
- 10.2.3 South America Tumor Targeting Peptides Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Tumor Targeting Peptides Sales by Country
- 11.1.1 Middle East and Africa Tumor Targeting Peptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Tumor Targeting Peptides Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Tumor Targeting Peptides Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Tumor Targeting Peptides Market Size by Country
- 11.2.1 Middle East and Africa Tumor Targeting Peptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Tumor Targeting Peptides Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Tumor Targeting Peptides Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Tumor Targeting Peptides Value Chain Analysis
- 12.1.1 Tumor Targeting Peptides Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Tumor Targeting Peptides Production Mode & Process
- 12.2 Tumor Targeting Peptides Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Tumor Targeting Peptides Distributors
- 12.2.3 Tumor Targeting Peptides Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,450USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst